*ST Spring released its 2026 interim report. First-half operating revenue was 59.1 million yuan, down 52.7% year on year, and net profit attributable to the parent company was a loss of 36.1 million yuan, down 2,840.8% year on year. Second-quarter revenue was 15.3 million yuan, down 63.0% year on year, with a net loss attributable to the parent company of 19.82 million yuan. The company's main business is divided into two segments: alcoholic beverages and fast-moving consumer goods, and big health. Revenue in the alcoholic beverages and fast-moving consumer goods segment fell 91.42% year on year, while the big health segment saw sales fall short of expectations due to insufficient consumer demand. During the reporting period, the company acquired a controlling stake in Xinjiang Yixuan Intelligent Computing Technology Co., Ltd. to expand its business.
Qinghai Spring Medicinal Resources Technology Co LtdReported a first-half net loss of 36.1 million yuan with revenue down 52.7% year on year.
Acquired as a controlling stake by *ST Spring to expand its business; no financial details or performance given.
